Drug development - from idea to patient
The drug industry is a key business area for Sweden. 2018 pharmaceutical drugs made up six per cent of export revenue and the area is an important part of the Swedish government's life science strategy.
RISE has competency across the entire value chain of drug development, from idea to patient. We can help you with process development, analysis, formulation and production of pharmaceuticals as well as clinical trials and early-on risk and safety evaluation.
